Stock Splits
By The Online Investor Staff, updated Mon., Feb. 6, 2:15 AM
| This Slide: #4 of 25 |
Slide #4. Lannett Company, Inc. (NYSE:LCI) — 1 for 4 Reverse Split
Announced:
1/25/2023
Stock Split:
1 for 4
Record Date:
2/6/2023
Pay Date:
2/7/2023
LCI Optionable?:
Yes
Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions. 
LCI Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the LCI Page at The Online Investor (in a new window) »
 Free LCI Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Hold (2.00 out of 4) 0th percentile
(ranked lower than approx. 100% of all stocks covered)
Analysts' Target Price: LCI Stock Forecast Based on Zacks ABR data; powered by Xignite |
